Strong Market Position RareMed Solutions is a leading player in the pharmaceutical manufacturing sector, distinguished by its award-winning patient satisfaction scores and rapid growth, making it a prime partner for expanding distribution channels and joint service offerings.

Technology Leadership With a focus on developing RarePath-based technologies and leveraging prominent tech stacks like Docker, Jenkins, and cloud security, RareMed demonstrates a commitment to innovation that can be harnessed for advanced digital health solutions and seamless integration opportunities.

Recent Growth & Recognition Achieving accolades such as the Fast 50 award and maintaining high growth rates from 2022 to 2024, RareMed is expanding its operational footprint, indicating potential for strategic partnerships and co-marketing initiatives grounded in its proven success in patient care and market expansion.

Expanding Service Offerings The recent partnership with PTC Therapeutics and launch of non-commercial pharmacy dispensing services reflect RareMed’s focus on expanding its service portfolio, presenting opportunities to collaborate on new therapy support solutions and distribution channels.

Strategic Revenue Base With revenue estimated between $250M to $500M and a sizable employee base, RareMed offers robust potential for enterprise-level partnerships, especially in the areas of complex therapy logistics, patient engagement, and technology-driven healthcare delivery.